Addition of a renin-angiotensin-aldosterone system inhibitor to a calcium channel blocker ameliorates arterial stiffness
Shunsuke Kiuchi,1 Shinji Hisatake,1 Muneyasu Kawasaki,2 Osamu Hirashima,2 Takayuki Kabuki,1 Junichi Yamazaki,1 Takanori Ikeda1 1Department of Cardiovascular Medicine, Toho University Faculty of Medicine, Tokyo, 2Division of Cardiology and Cardiovascular Surgery, Misato Central General Hospital, Sait...
Guardado en:
Autores principales: | Kiuchi S, Hisatake S, Kawasaki M, Hirashima O, Kabuki T, Yamazaki J, Ikeda T |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b580cb744b3d44129ce09b4288b89ebc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Renin–Angiotensin–Aldosterone System and Coronavirus Disease 2019
por: Eliecer Coto, et al.
Publicado: (2021) -
Editorial: New Trends in the Renin-Angiotensin-Aldosterone System in Cardiovascular Disease
por: Ewa Szczepanska-Sadowska, et al.
Publicado: (2021) -
Comparison of hypertension prevalence and the use of renin-angiotensin-aldosterone system blockers in hospitalized patients with COVID-19 and non-COVID-19 viral pneumonia
por: Selçuk Görmez, et al.
Publicado: (2021) -
COVID-19 pathophysiology may be driven by an imbalance in the renin-angiotensin-aldosterone system
por: Susanne Rysz, et al.
Publicado: (2021) -
Renin-angiotensin-aldosterone system in the elderly: rational use of aliskiren in managing hypertension
por: Karl Andersen
Publicado: (2009)